Abstract
BackgroundVariations in light exposure are associated with changes in inflammation and coagulation. The impact of light spectra on venous (VT) and arterial thrombosis is largely unexplored. ObjectivesTo investigate the impact of altering light spectrum on platelet function in thrombosis. MethodsWild type (WT) C57BL/6J mice were exposed to ambient (micewhite, 400lux), blue (miceblue, 442nm, 1,400lux), or red light (micered, 617nm, 1,400lux) with 12:12 hour light:dark cycle for 72 hours. After 72 hours of light exposure, platelet aggregation, activation, transcriptomic, and metabolomic changes were measured. The ability of released products of platelet activation to induce thrombosis-generating NET formation was quantified. Subsequent thrombosis was measured using murine models of VT and stroke. To translate our findings to human patients, light filtering cataract patients were evaluated over an 8-year period for rate of VTE with multivariable logistic regression clustered by hospital. ResultsExposure to long wavelength red light resulted in reduced platelet aggregation and activation. RNA-seq analysis demonstrated no significant transcriptomic changes between micered and micewhite. However, there were global metabolomic changes in platelets from micered compared to micewhite. Releasate from activated platelets resulted in reduced NET formation. Micered also had reduced VT weight and brain infarct size following stroke. On subgroup analysis of cataract patients, patients with a history of cancer have lower lifetime risk of VTE after implantation with lenses that filter low wavelength light. ConclusionsLight therapy may be a promising approach to thrombus prophylaxis by specifically targeting the intersection between innate immune function and coagulation.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call